Dialysis Corporation of America Announces the Development of New Facility in Ohio


HANOVER, Md., Oct. 25, 2004 (PRIMEZONE) -- Dialysis Corporation of America (Nasdaq:DCAI) announced the development of a new facility in Cincinnati, Ohio, through an affiliation with the University of Cincinnati, College of Medicine, to be located in the greater Cincinnati area.

President & CEO Stephen Everett commented, "We look forward to the opportunity to be working with this outstanding group of physicians and University, as we expand our dialysis programs that service the people of Cincinnati, Ohio. This new facility will be our second in the area, and is in line with DCA's overall development strategy."

The new facility will offer state-of-the-art equipment and technology, be designed with patient comfort in mind, and include 15 treatment stations, along with a Peritoneal Suite for patients opting for that modality.

Dialysis Corporation of America owns and operates freestanding kidney hemodialysis centers located in Georgia, Maryland, Ohio, Pennsylvania, New Jersey, South Carolina, and Virginia, and provides in-hospital dialysis services on a contract basis to certain hospitals located in the those states. The company provides patients with their choice of a full range of quality in-center, acute or at-home hemodialysis services.

This release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results and plans to differ materially from those anticipated. Those factors include, but are not limited to, certain delays beyond the company's control with respect to future business events, the highly competitive environment in the establishment and operation of dialysis centers, the ability to develop or acquire additional dialysis facilities, whether patient bases of these facilities can expand to provide profitability, regulation of dialysis operations, government rate determination for Medicare reimbursement, and other risks detailed in the company's filings with the Securities and Exchange Commission, particularly as described in the company's annual report on Form 10-K for the fiscal year ended December 31, 2003.

Other Dialysis Corporation of America press releases, corporate profile, corporate governance materials, and the most recent annual report on Form 10-K for the year ended December 31, 2003, our two quarterly reports for fiscal 2004, and other filings with the Securities and Exchange Commission, are available on Dialysis Corporation of America's internet home page: http://www.dialysiscorporation.com.



            

Contact Data